Login

John Burt, chief executive of Abzena PLC 00:00:00

Share On Facebook Share On Twitter

John Burt, chief executive of Abzena PLC (LON:ABZA), pitches the company to investors.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
New Year Tips with Susan Zimmerman | Susan Zimmerman - Co-Founder and Program Director of Mindful Asset Planning
00:10:00
Inside Cartherics: A Comprehensive 5-Minute Investor Overview|Professor Alan Trounson ,CEO,CARTHERICS
00:10:00
Wilson Romanini Discusses Current Trends and New Developments in the Fertilizer Sector | Wilson Romanini, CEO, Vittia Fertilizantes e Biológicos SA.
00:10:00
Navigating Growth and Innovation: CY4GATE's Expansion Through Strategic Acquisitions | Emanuele Galtieri, CEO, CY4Gate SpA.
00:10:00
Empowering Financial Advisors: Virtue Capital Management's Turnkey Approach | President, Virtue Capital Management
00:10:00
Giving Back: Video Series Part 2 | Matt Roberts, Chief Planning Officer, Financial Planner of Syverson Strege
00:10:00
Exclusive Tour: Inside Blue Bird's Facility with CEO Phil Horlock | Phil Horlock - CEO of Blue Bird Corporation
00:10:00
Building a Global VC firm & Learnings From Indian Founders|Vinny Pujji,Managing Partner,Left Lane Capital
00:10:00
MCCA 2020 Rainmakers Award Honoree | Sherrese M. Smith - Global Managing Partner of Paul Hastings
00:10:00
Goldman Sachs' Strategic Commitment to Small Businesses and Economic Resilience | David Solomon, CEO,  Goldman Sachs.
00:10:00
new industries and profoundly influenced productivity, creativity, and the global economy|Casey Aylward,Partner,Accel
00:10:00
NCR Chairman & CEO Bill Nuti discusses career opportunities and shares his comments.|Michael D. Hayford Retiring as NCR Chief Executive Officer

© 2026 Nehu